Shancheng Ren

RED-ML: a novel, effective RNA editing detection method based on machine learning

Xun Xu, Liqin Xu, Yong Hou, 2017, GigaScience.

Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome.

Yang Wang, Wei Zhang, Chuanliang Xu, 2015, Urologic oncology.

The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction of prostate cancer in China.

Chuanliang Xu, Xu Gao, Shancheng Ren, 2008, Urology.

The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA

Wei Zhang, Shancheng Ren, Yao-ming Li, 2020, International journal of cancer.

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4

Bo Dai, Qiang Ding, Henrik Gronberg, 2012, Nature Genetics.

Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer

Chao Qin, Fang Liu, Qiang Ding, 2015, Nature Communications.

Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer*

Xin Lu, Chuanliang Xu, Xinjie Zhao, 2015, Molecular & Cellular Proteomics.

The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.

Chuanliang Xu, Yi Sun, Xu Gao, 2013, Urologic oncology.